{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-259591","form_type":"8-K","ticker":"AGIO","cik":"0001439222","company_name":"AGIOS PHARMACEUTICALS, INC.","filed_at":"2022-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.666363+00:00","generated_at":"2026-06-23T04:40:38.902367+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Agios amends severance plan; expands C-Level definition, alters equity vesting rules","bullets":["C-Level Employee definition expanded to include any job title above Senior Vice President.","New-Hire Equity Awards granted after October 6, 2022 will have accelerated vesting on non-Change-of-Control termination or death/disability.","Change-of-Control Termination now triggers full vesting of service-based equity awards; performance awards per original plan terms.","Post-Change-of-Control amendment/termination restriction period increased from 12 to 18 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-259591","json":"https://secwatch.observer/filing/0001193125-22-259591.json","markdown":"https://secwatch.observer/filing/0001193125-22-259591.md","text":"https://secwatch.observer/filing/0001193125-22-259591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522259591/0001193125-22-259591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522259591/d363139d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:40:38.902367+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}